Compare TG Therapeutics Inc (TGTX) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Wipro Limited — how do they compare? TG Therapeutics Inc trades at $50 (market cap $7.64B), while Wipro Limited trades at $1.98 (market cap $19.07B). The key difference: Wipro Limited is far larger — about 2.5× TG Therapeutics Inc's market cap, and Wipro Limited pays a 4.4% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WIT | |
|---|---|---|
Market Cap | $7.64B | $19.07B |
Sector | Health | Technology |
52-Week High | $59.06 | $3.06 |
52-Week Low | $26.94 | $1.78 |
Enterprise Value | $7.84B | $17.16B |
Dividend Yield | — | 4.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
